These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30848578)

  • 1. The Role of Progesterone in Cellular Apoptosis of Skin and Lung in a Bleomycin-injured Mouse Model.
    Vafashoar F; Poormoghim H; Mousavizadeh K; Mousavi Shabestari T; Tavasoli A; Javadmoosavi SA; Mojtabavi N
    Iran J Allergy Asthma Immunol; 2019 Feb; 18(1):100-107. PubMed ID: 30848578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gelatinases Increase in Bleomycin-induced Systemic Sclerosis Mouse Model.
    Vafashoar F; Mousavizadeh K; Poormoghim H; Tavasoli A; Musavi Shabestari T; Javadmoosavi SA; Mojtabavi N
    Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):182-189. PubMed ID: 31066254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone Aggravates Lung Fibrosis in a Mouse Model of Systemic Sclerosis.
    Vafashoar F; Mousavizadeh K; Poormoghim H; Haghighi A; Pashangzadeh S; Mojtabavi N
    Front Immunol; 2021; 12():742227. PubMed ID: 34912332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
    Ohashi T; Yamamoto T
    Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma.
    Yamamoto T; Takagawa S; Katayama I; Yamazaki K; Hamazaki Y; Shinkai H; Nishioka K
    J Invest Dermatol; 1999 Apr; 112(4):456-62. PubMed ID: 10201529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Protective Effects of Bevacizumab in Bleomycin-Induced Experimental Scleroderma.
    Koca SS; Ozgen M; Dagli AF; Gozel N; Ozercan IH; Isik A
    Adv Clin Exp Med; 2016; 25(2):249-53. PubMed ID: 27627557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrogenic effects of C-C chemokine receptor type 2 antagonist in a bleomycin-induced scleroderma model.
    Ishikawa M; Yamamoto T
    Exp Dermatol; 2021 Jan; 30(1):179-184. PubMed ID: 32096250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-21 induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycin-induced fibrosis in mice.
    Lei L; Zhong XN; He ZY; Zhao C; Sun XJ
    Cell Biol Int; 2015 Apr; 39(4):388-99. PubMed ID: 25492803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.
    Meng M; Tan J; Chen W; Du Q; Xie B; Wang N; Zhu H; Wang K
    Front Immunol; 2019; 10():1861. PubMed ID: 31481954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin-17 levels in bleomycin-induced dermal fibrosis.
    Karatas A; Celik C; Oz B; Akar ZA; Etem EO; Dagli AF; Koca SS
    Int J Rheum Dis; 2021 Jun; 24(6):795-802. PubMed ID: 33835703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
    Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
    Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse model of dermal fibrosis induced by one-time injection of bleomycin-poly(L-lactic acid) microspheres.
    Shibusawa Y; Negishi I; Tabata Y; Ishikawa O
    Rheumatology (Oxford); 2008 Apr; 47(4):454-7. PubMed ID: 18316335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
    Yamamoto T; Nishioka K
    Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
    Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
    Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis.
    Fineschi S; Bongiovanni M; Donati Y; Djaafar S; Naso F; Goffin L; Argiroffo CB; Pache JC; Dayer JM; Ferrari-Lacraz S; Chizzolini C
    Am J Respir Cell Mol Biol; 2008 Oct; 39(4):458-65. PubMed ID: 18458239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis.
    Ruzehaji N; Avouac J; Elhai M; Frechet M; Frantz C; Ruiz B; Distler JH; Allanore Y
    Arthritis Res Ther; 2015 May; 17(1):145. PubMed ID: 26025306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.